Regeneron Announces Presentation at the 44th Annual J.P. Morgan Healthcare Conference GlobeNewswire December 22, 2025 TARRYTOWN, N.Y., Dec. 22, 2025 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026. The presentation is scheduled for 2:15 p.m. Pacific Time (5:15 […]
Horizon Bank Announces Appointment of Senior Vice President, Director of Human Resources, Pam Zarazee GlobeNewswire December 22, 2025 MICHIGAN CITY, Ind., Dec. 22, 2025 (GLOBE NEWSWIRE) — Horizon Bank, a commercial banking subsidiary of Horizon Bancorp, Inc. (NASDAQ GS: HBNC), announced today the appointment of Pam Zarazee as the Senior Vice President, Director of Human
Toronto, Ontario–(Newsfile Corp. – December 22, 2025) – The Canadian Securities Exchange (“CSE” or “the Exchange”) today welcomed the listing of Predictiv AI Inc. (“Predictiv AI” or the “Company”). The Toronto-based Company’s common shares, which were previously listed on the TSX Venture Exchange’s NEX board, began trading on the CSE today under the symbol PAI
(NASDAQ:CELU),(NASDAQ:CELUW), FLORHAM PARK, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company addressing age-related and degenerative diseases, today announced the closing of its previously disclosed financing transactions with Philip A. Barach, co-founder and former president of DoubleLine Capital LP. At the closing, Celularity received $10.00 million
(NASDAQ:HTO), SAN JOSE, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) — H2O America (NASDAQ: HTO), a leading investor-owned, pure-play water and wastewater utility, today announced the appointment of Nicholas Whitley as vice president of business development, effective December 22. In this role, Whitley will lead H2O America's business development initiatives, including the identification, evaluation and execution
(NASDAQ:NVA),(NASDAQ:NVAWW),(OTC US:NVAAF),(Other OTC:NVAAF),(Boerse Frankfurt – Freiverkehr:QM3),(AUST:NVA.AX), Melbourne, Australia, Dec. 22, 2025 (GLOBE NEWSWIRE) — Nova Minerals Limited (“Nova” and the “Company”) (Nasdaq NVA, NVAWW) (ASX: NVA), FRA: QM3)), a gold, antimony and critical minerals exploration stage company focused on advancing the Estelle Gold and Critical Minerals Project in Alaska, today announced the closing of an
DENVER, Dec. 22, 2025 (GLOBE NEWSWIRE) — Atlas Technical Consultants (Atlas), a leading infrastructure and environmental solutions provider, has announced Chris Robinson as Director of Nuclear Services. Robinson will be based in the firm's Idaho Falls office, where Atlas has supported the Idaho National Laboratory (INL) for years, most recently helping with the Oklo Aurora
(NASDAQ:FIVE), PHILADELPHIA, PA, Dec. 22, 2025 (GLOBE NEWSWIRE) — Five Below, Inc. (NASDAQ: FIVE), the trend-right, high-quality extreme-value retailer for the kid and the kid in all of us, today announced that management is currently scheduled to host a fireside chat at the 2026 ICR Conference in Orlando, Florida, on Monday, January 12, 2026, at
(NASDAQ:AMRX), Approvals expand Amneal's biosimilars portfolio Company expects to commercialize six biosimilars across eight presentations by 2027 BRIDGEWATER, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (NASDAQ: AMRX) and mAbxience, a Fresenius Kabi majority-owned group with partial ownership from Insud Pharma, today announced that the U.S. Food and Drug
(NASDAQ:BBIO), PALO ALTO, Calif., Dec. 22, 2025 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a new type of biopharmaceutical company focused on genetic diseases, today announced that on December 18, 2025, the compensation committee of BridgeBio's board of directors approved equity grants to 9 new employees in restricted stock units